Twist Bioscience launches Long Oligos to fuel drug development, DNA data storage and gene editing research
At up to 300 bases, or nucleotides, in length this is the longest commercial oligo offering by continuous chemical synthesis in the industry.
CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS, MOVING CLOSER TO ITS 2020 OBJECTIVE OF 50:50 BIO-PHARMA SPLIT
Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.
SuperSonic Imagine announces that it has received a binding offer from the Hologic group to acquire 100% of the Company’s capital for a price of €1.50 per share
Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital.
Seqens is unveiling its main innovation and development centre near Paris
SEQENS'Lab is a 34,000 sqm science platform and centre of excellence for developing a totally unique package of R&D services.
Xeris Pharmaceuticals Announces Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its stable liquid glucagon.
Dr Jan Ohrstrom takes on Executive Leadership of BIOM'UP
Dr Ohrstrom has been Chairman of the Board of Directors since 2015.
Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan
Mr Chan, former CEO of Magellan, brings over 35 years of experience as both a director and operational executive in the technology and life sciences space.
CEVA SANTE ANIMALE AND IDT BIOLOGIKA GMBH ANNOUNCE AGREEMENT
CEVA to acquire the IDT Animal Health business, expanding its global vaccine portfolio and boosting swine innovation.
SGH Healthcaring - An original primary packaging range for nutraceuticals
Having recently acquired Eskiss Packaging, the group now offers a wide range of primary packagaing for the food supplement sector.